kabutan

TORII PHARMA, 35% Decrease in Ordinary Profit for The Current Fiscal Year

Fri Feb 7, 2025 3:30 pm JST Earnings

4551 TORII PHARMACEUTICAL CO., LTD. 【J-GAAP】

Earnings Report

TORII PHARMACEUTICAL CO., LTD. <4551> [TSE Prime] announced its financial results after the market closed on February 7th (15:30). The ordinary profit (non-consolidated) for the fiscal year ending December 2024 expanded 30.5% from the previous period to 6.92 billion yen. However, for the fiscal year ending December 2025, the profit is expected to drop by 35.0% from the previous period to 4.5 billion yen.

In the most recent three-month period, from October to December (4Q), the ordinary profit grew 12.4% from the same period last year, reaching 2.24 billion yen. The operating profit margin rose from 11.8% in the same period last year to 12.5%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 48,896 5,540 5,537 3,944 140.4 100 Feb 10, 2023 J-GAAP
Dec, 2023 54,638 5,035 5,307 4,119 146.6 120 Feb 9, 2024 J-GAAP
Dec, 2024 60,426 6,798 6,926 5,042 179.4 120 Feb 7, 2025 J-GAAP
YoY +10.6% +35.0% +30.5% +22.4% +22.4%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance 61,200 6,700 6,800 5,100 181.4 120 Oct 31, 2024 J-GAAP
Dec, 2024 Results 60,426 6,798 6,926 5,042 179.4 120 Feb 7, 2025 J-GAAP
Revision Rate -1.3% +1.5% +1.9% -1.1% -1.1%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 28,309 3,141 2,985 2,221 79.0 60 Jul 31, 2024 J-GAAP
Jan - Jun, 2025 Guidance ー ー ー ー － 60 Feb 7, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 54,638 5,035 5,307 4,119 146.6 120 Feb 9, 2024 J-GAAP
Dec, 2024 60,426 6,798 6,926 5,042 179.4 120 Feb 7, 2025 J-GAAP
Dec, 2025 Guidance 64,700 4,100 4,500 3,400 120.9 120 Feb 7, 2025 J-GAAP
YoY +7.1% -39.7% -35.0% -32.6% -32.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 15,506 1,824 1,992 1,751 62.3 11.8 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 13,451 1,383 1,166 878 31.3 10.3 Apr 26, 2024 J-GAAP
Apr - Jun, 2024 14,858 1,758 1,819 1,343 47.8 11.8 Jul 31, 2024 J-GAAP
Jul - Sep, 2024 15,024 1,520 1,701 1,304 46.4 10.1 Oct 31, 2024 J-GAAP
Oct - Dec, 2024 17,093 2,137 2,240 1,517 54.0 12.5 Feb 7, 2025 J-GAAP
YoY +10.2% +17.2% +12.4% -13.4% -13.4%

Related Articles